Last update :
13/08/2020
Anticancer drug   Daunorubicin/cytarabine liposomale  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Incompatibilities Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Vyxeos France, Germany, Great Britain, United States of America
Stability in solutions   Injection   Stability in solutions : Daunorubicin/cytarabine liposomale     
Container Solvent Concentration Temperature Storage Length of time References
Glass Water for Injection 2.2 / 5 mg/mL 2-8°C Not specified
4 Hour
4355
Glass Water for Injection 2.2 / 5 mg/mL 2-8°C Not specified
4 Hour
4355
Polyolefine NaCl 0,9% or Glucose 5% 0.087 / 0.195 mg/mL 2-8°C Not specified
4 Hour
4355
Polyolefine NaCl 0,9% or Glucose 5% 0.176 / 0.4 mg/mL 2-8°C Not specified
4 Hour
4355

  Mentions Légales